Preclinical disease and preventive strategies in IBD

Bárbara Morão, Joana Torres

Research output: Contribution to journalReview articlepeer-review

2 Citations (Scopus)

Abstract

There is growing evidence that inflammatory bowel disease has a preclinical phase that precedes disease symptoms, during which immune system activation has already occurred and inflammatory pathways have been primed, setting the stage for disease to expand and leading up to clinical diagnosis. Gaining insight to this pre-diagnosis period could improve our knowledge about disease pathogenesis and potentially result in the detection of biomarkers that could predict disease development. The ultimate goal of such research is to identify a population at risk for developing IBD, so preventive strategies could be implemented and disease prevention be achieved.

Original languageEnglish
Pages (from-to)110-115
Number of pages6
JournalCurrent Opinion in Pharmacology
Volume55
DOIs
Publication statusPublished - Dec 2020
Externally publishedYes

Fingerprint

Dive into the research topics of 'Preclinical disease and preventive strategies in IBD'. Together they form a unique fingerprint.

Cite this